| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Paratek Pharmaceuticals Inc (NASDAQ: PRTK)
PRTK Technical Analysis
5
| As on 9th Jun 2023 PRTK STOCK Price closed @ 2.17 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 2.88 & Strong Sell for SHORT-TERM with Stoploss of 4.05 we also expect STOCK to react on Following IMPORTANT LEVELS. |
PRTKSTOCK Price
| Open | 2.20 | Change | Price | % |
| High | 2.21 | 1 Day | -0.02 | -0.91 |
| Low | 2.17 | 1 Week | 0.64 | 41.83 |
| Close | 2.17 | 1 Month | 0.65 | 42.76 |
| Volume | 3103400 | 1 Year | -2.34 | -51.88 |
| 52 Week High 4.77 | 52 Week Low 1.37 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| PRTK Daily Charts |
PRTK Intraday Charts |
Whats New @ Bazaartrend |
PRTK Free Analysis |
|
|
PRTK Important Levels Intraday
| RESISTANCE | 2.25 |
| RESISTANCE | 2.22 |
| RESISTANCE | 2.21 |
| RESISTANCE | 2.19 |
| SUPPORT | 2.15 |
| SUPPORT | 2.13 |
| SUPPORT | 2.12 |
| SUPPORT | 2.09 |
PRTK Forecast April 2024
| 4th UP Forecast | 4.6 |
| 3rd UP Forecast | 3.82 |
| 2nd UP Forecast | 3.34 |
| 1st UP Forecast | 2.86 |
| 1st DOWN Forecast | 1.48 |
| 2nd DOWN Forecast | 1 |
| 3rd DOWN Forecast | 0.52 |
| 4th DOWN Forecast | -0.26 |
PRTK Weekly Forecast
| 4th UP Forecast | 3.19 |
| 3rd UP Forecast | 2.86 |
| 2nd UP Forecast | 2.66 |
| 1st UP Forecast | 2.46 |
| 1st DOWN Forecast | 1.88 |
| 2nd DOWN Forecast | 1.68 |
| 3rd DOWN Forecast | 1.48 |
| 4th DOWN Forecast | 1.15 |
PRTK Forecast2024
| 4th UP Forecast | 8.93 |
| 3rd UP Forecast | 6.76 |
| 2nd UP Forecast | 5.42 |
| 1st UP Forecast | 4.08 |
| 1st DOWN Forecast | 0.26 |
| 2nd DOWN Forecast | -1.08 |
| 3rd DOWN Forecast | -2.42 |
| 4th DOWN Forecast | -4.59 |
Paratek Pharmaceuticals Inc ( NASDAQ USA Symbol : PRTK )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
PRTK Business Profile
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectrum antibiotic for the treatment of adult patients with community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections caused by susceptible pathogens; and SEYSARA, a tetracycline designed for the treatment of moderate to severe acne vulgaris. The company has license and collaboration agreements with Zai Lab (Shanghai) Co., Ltd. and Allergan plc; license agreement with Tufts University to develop and commercialize products for the treatment or prevention of bacterial or microbial diseases, or medical conditions; and contract with Biomedical Advanced Research and Development Authority to support the development of NUZYRA for the treatment of pulmonary anthrax. It also has license agreement with Tetraphase Pharmaceuticals, Inc. to develop, import, and sell the XERAVATM product, which is used for the treatment of complicated intra-abdominal infections caused by bacteria. The company was founded in 1996 and is headquartered in Boston, Massachusetts. Address: 75 Park Plaza, Boston, MA, United States, 02116
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service